You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

34 search results for: patient case

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma <b>Patient</b>s?
expert video

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

Pulmonology
Professors Celeste Porsbjerg and Klaus Rabe and Dr Mario Castro discuss the pathophysiology of airway remodeling and its impact on patients with severe asthma.
View more
Practical Considerations for the Management of Children With Moderate-to-severe Atopic Dermatitis - Expert Interview
expert video

Practical Considerations for the Management of Children With Moderate-to-severe Atopic Dermatitis - Expert Interview

Dermatology
Watch ADVENT now: Dermatologist Amy Paller discusses unmet needs and therapeutic considerations for pediatric patients with atopic dermatitis
View more
ERS 2024 | Can Biologics Affect Airway Remodeling?
expert video

ERS 2024 | Can Biologics Affect Airway Remodeling?

Pulmonology
Dr Mario Castro presents the latest clinical data on biologics showcasing their effect on airway remodeling parameters and airway hyperresponsiveness in patients with severe asthma.
View more
Beyond the Signs ​and Symptoms: ​The Developmental Burden of AD in Children
expert video

Beyond the Signs ​and Symptoms: ​The Developmental Burden of AD in Children

Dermatology
Highlights from the ESPD 2023 ADVENT symposium: Exploring burden and comorbidities associated with moderate-to-severe atopic dermatitis in children.
View more
Early Intervention in Children with Atopic Dermatitis: A Window of Opportunity?
expert video

Early Intervention in Children with Atopic Dermatitis: A Window of Opportunity?

Dermatology
Highlights from the ESPD 2023 ADVENT symposium, exploring burden, skin barrier normalization, and current treatments for pediatric atopic dermatitis.
View more
Early Intervention in AD: Latest Clinical and Real-world Data
expert video

Early Intervention in AD: Latest Clinical and Real-world Data

Dermatology
Highlights from ESPD 2023 ADVENT: Reviewing the current treatment landscape and the potential for early intervention in pediatric atopic dermatitis.
View more
Targeting Type 2 Inflammation: ​Skin Barrier Normalization​
expert video

Targeting Type 2 Inflammation: ​Skin Barrier Normalization​

Dermatology
Highlights from ESPD 2023 ADVENT: Uncovering how type 2 inflammation influences skin barrier dysfunction in atopic dermatitis.
View more
Atopic Dermatitis (AD) in Children: Early Intervention Can Reduce Long-Term Disease Impact
expert video

Atopic Dermatitis (AD) in Children: Early Intervention Can Reduce Long-Term Disease Impact

Dermatology
Highlights from the 2023 World Congress of Dermatology ADVENT symposium, exploring intervention considerations for children with atopic dermatitis.
View more
Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children
expert video

Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children

Dermatology
Explore WCD 2023 ADVENT symposium's insights into managing short and long-term challenges of pediatric atopic dermatitis.
View more
Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children - Expert Interview
expert video

Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children - Expert Interview

Dermatology
Watch ADVENT now: Dermatologist Mark Koh describes the Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children.
View more
Emerging Clinical Data in Children With Atopic Dermatitis- Q&As
expert video

Emerging Clinical Data in Children With Atopic Dermatitis- Q&As

Dermatology
Explore the WCD 2023 ADVENT symposium’s insights into current and emerging treatment strategies for managing pediatric atopic dermatitis.
View more
Emerging Clinical Data in Children With Atopic Dermatitis
expert video

Emerging Clinical Data in Children With Atopic Dermatitis

Dermatology
Explore WCD 2023 ADVENT symposium's insights into current and emerging treatment strategies for managing pediatric atopic dermatitis.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: BrazilChange country/region